HDL, or non-HDL: that is the question. Possibilities of pharmacological treatment in residual dyslipidaemia

László Bajnok
  • Orvosi Hetilap, January 2014, Akademiai Kiado
  • DOI: 10.1556/oh.2014.29797

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1556/oh.2014.29797